Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States

INTRODUCTION: Achieving glycemic control can help reduce complications of type 2 diabetes (T2D). This study compared the pharmacy cost per responder and number needed to treat (NNT) of tirzepatide 5 mg, 10 mg, and 15 mg versus semaglutide 1 mg to achieve glycemic, weight loss, and composite treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mody, Reema R., Meyer, Kellie L., Ward, Jennifer M., O’Day, Ken B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597950/
https://www.ncbi.nlm.nih.gov/pubmed/37770706
http://dx.doi.org/10.1007/s13300-023-01470-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597950/
https://www.ncbi.nlm.nih.gov/pubmed/37770706
http://dx.doi.org/10.1007/s13300-023-01470-w

Ejemplares similares